Table 3. HER2 and classic clinicopathological features.
| Characteristics | HER2 Negative 92 (86.7%) |
HER2 Positive 14 (13.2%) |
p |
|---|---|---|---|
| Age >65 years <65 years |
64 (69.6) 28 (30.4) |
11 (78.6) 3 (21.4) |
0.490 |
| Gender Male Female |
57 (62.0) 35 (38.0) |
11 (78.6) 3 (21.4) |
0.227 |
| Tumour location Proximal Distal Unknown |
29 (31.5) 63 (68.5) 0 (0.0) |
6 (42.9) 7 (50.0) 1 (7.1) |
0.074 |
| Lauren subtype Intestinal Non-intestinal |
63 (68.5) 29 (31.5) |
14 (100.0) 0 (0.0) |
0.010 |
| Histological grade Low Grade (G1–G2) High degree (G3–G4) |
51 (55.4) 41 (44.6) |
13 (92.9) 1 (7.1) |
0.008 |
| Tumour invasion (T) T1–T2 T3–T4 |
33 (35.9) 59 (64.1) |
10 (71.4) 4 (28.6) |
0.018 |
| Lymph node involvement (N) N0 N1-3 |
43 (46.7) 49 (53.3) |
5 (35.7) 9 (64.3) |
0.568 |
| Lymphovascular invasion No Yes |
42 (45.7) 50 (54.3) |
6 (42.9) 8 (57.1) |
0.539 |
| Perineural invasion No Yes |
46 (50.0) 46 (50.0) |
6 (42.9) 8 (57.1) |
0.776 |
| Adjuvant therapy No Yes |
38 (41.3) 54 (58.7) |
8 (57.1) 6 (42.9) |
0.141 |